Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxaliplatin in Hepatocellular Cancer
NCT00052364Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Sep 2002
- Primary completion
- Jan 2006
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin in hepatocellular carcinoma (HCC), sponsored by National Cancer Institute. Started Sep 2002; status: completed.
02
Drugs
oxaliplatin
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00052364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00052364.